V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002003 | 230004465 | null | null | Palliative (P) | 2021-04-13 | 2021-04-21 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100970893 |
| 230002005 | 230004467 | 1.7 | 65.6 | null | 2019-03-12 | 2019-04-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100833224 |
| 230002008 | 230004470 | null | 66.4 | null | 2019-08-04 | 2019-12-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101815315 |
| 230002010 | 230004472 | 1.64 | 66.2 | null | 2020-02-07 | 2020-02-29 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100796228 |
| 230002011 | 230004473 | null | null | null | 2019-01-10 | 2019-01-16 | null | null | null | IPILIMUMAB + NIVOLUMAB | 100575094 |
| 230002013 | 230004475 | null | null | null | null | 2019-03-22 | Cisplatin | null | null | PEMBROLIZUMAB | 101241573 |
| 230002015 | 230004477 | 1.62 | 80 | null | null | 2019-08-09 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100897227 |
| 230002019 | 230004481 | 1.58 | 68 | null | null | 2021-11-10 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100775843 |
| 230002020 | 230004482 | 1.66 | 123.7 | Adjuvant (A) | 2019-05-24 | 2019-05-31 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100290984 |
| 230002021 | 230004483 | 1.59 | 87 | null | 2015-11-20 | 2019-04-09 | NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100244440 |
| 230002022 | 230004484 | 1.66 | 90.3 | Palliative (P) | null | 2019-04-24 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101427882 |
| 230002023 | 230004485 | null | null | null | 2017-11-01 | 2017-11-18 | PEMBROLIZUMAB | 02 | null | CYCLOPHOSPHAMIDE | 101154209 |
| 230002027 | 230004489 | 1.7 | 101 | Palliative (P) | null | 2019-09-26 | null | null | N | CISPLATIN | 101310432 |
| 230002028 | 230004490 | null | null | null | null | 2018-09-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100214243 |
| 230002030 | 230004492 | 1.64 | 101 | null | 2019-11-16 | 2019-12-29 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101813544 |
| 230002031 | 230004493 | null | null | null | null | 2019-08-03 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101678575 |
| 230002037 | 230004497 | 1.6 | 66 | null | 2019-08-15 | 2019-08-16 | null | null | null | PEMBROLIZUMAB | 100762527 |
| 230002038 | 230004498 | 1.65 | 67 | null | 2020-12-28 | 2021-01-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100385539 |
| 230002040 | 230004499 | 1.75 | 62.7 | Palliative (P) | 2021-03-01 | 2021-03-03 | null | 02 | N | NIVOLUMAB | 100993742 |
| 230002041 | 230004500 | 1.5 | 86.3 | Palliative (P) | null | 2018-07-04 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100942257 |
| 230002042 | 230004501 | 1.64 | 91.8 | null | null | 2020-09-15 | Carboplatin + Docetaxel | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100015993 |
| 230002045 | 230004503 | null | null | null | 2017-11-29 | 2017-11-29 | null | 02 | null | ETOPOSIDE | 101121861 |
| 230002046 | 230004504 | 1.62 | 94.6 | null | null | 2017-10-13 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100134337 |
| 230002047 | 230004505 | 1.61 | 64.3 | null | 2019-10-28 | 2019-10-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101483966 |
| 230002048 | 230004506 | 1.68 | 65.4 | null | 2017-09-11 | 2017-09-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100707205 |
| 230002049 | 230004507 | null | null | Palliative (P) | 2018-12-30 | 2019-01-13 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101426792 |
| 230002052 | 230004510 | 1.75 | 66.4 | Curative (C) | 2018-03-23 | 2018-08-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100523092 |
| 230002053 | 230004511 | null | null | null | 2019-09-05 | 2019-09-14 | null | null | null | BEVACIZUMAB | 100269365 |
| 230002054 | 230004512 | 1.51 | 86.9 | null | 2019-11-23 | 2019-11-25 | PACLITAXEL | 02 | null | PACLITAXEL | 100789824 |
| 230002055 | 230004513 | null | null | Neo-adjuvant (N) | 2016-06-08 | 2016-08-01 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101799681 |
| 230002056 | 230004514 | null | null | null | 2021-06-29 | 2021-06-29 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101262532 |
| 230002057 | 230004515 | 1.6 | 80.2 | Palliative (P) | null | 2016-11-28 | Carboplatin + Docetaxel | 02 | N | PEMBROLIZUMAB | 100730585 |
| 230002059 | 230004516 | 1.63 | 71.5 | null | null | 2019-10-19 | null | 02 | null | TRIAL UNSPECIFIED | 101745483 |
| 230002065 | 230004521 | null | null | Palliative (P) | 2016-11-29 | 2017-02-18 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101004899 |
| 230002066 | 230004522 | 1.63 | 68.4 | null | 2020-04-25 | 2020-06-13 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101067457 |
| 230002067 | 230004523 | 1.64 | 47.9 | null | null | 2017-11-18 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101408196 |
| 230002068 | 230004524 | 1.69 | 69.8 | Palliative (P) | 2022-02-09 | 2022-02-10 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101506674 |
| 230002069 | 230004525 | 1.64 | 64.2 | null | null | 2019-11-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100804248 |
| 230002070 | 230004526 | 1.54 | 91.9 | null | 2021-02-02 | 2021-02-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101371848 |
| 230002072 | 230004528 | 1.57 | 58.3 | null | 2017-07-22 | 2017-07-22 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100642775 |
| 230002074 | 230004530 | 1.61 | 61 | null | 2020-02-28 | 2020-09-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100788758 |
| 230002075 | 230004531 | 1.58 | 77 | null | 2019-01-13 | 2019-01-27 | Olaparib | 02 | null | OLAPARIB | 101208932 |
| 230002076 | 230004532 | 1.45 | 75.8 | null | 2016-12-17 | 2016-12-17 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101269238 |
| 230002077 | 230004533 | 1.67 | 80.8 | null | 2017-04-26 | 2017-05-01 | null | 99 | null | CARBOPLATIN | 101474197 |
| 230002078 | 230004534 | 1.57 | 75 | null | 2017-11-18 | 2017-11-26 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101221344 |
| 230002079 | 230004535 | 1.59 | 75 | null | 2019-05-17 | 2019-05-22 | ETOPOSIDE + IFOSFAMIDE | 02 | null | IPILIMUMAB + NIVOLUMAB | 101556207 |
| 230002086 | 230004542 | 1.63 | 89 | Palliative (P) | 2020-12-25 | 2021-01-17 | null | 02 | N | CAPECITABINE + CARBOPLATIN | 100580166 |
| 230002087 | 230004543 | 1.55 | 95.2 | Palliative (P) | 2019-03-28 | 2019-04-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101282336 |
| 230002090 | 230004546 | 1.58 | 69.7 | null | 2019-02-20 | 2019-05-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | CISPLATIN | 101765445 |
| 230002091 | 230004547 | 1.56 | 65.6 | null | 2020-10-08 | 2020-10-08 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100716171 |